China is investing heavily in cutting-edge genetic experiments. It’s part of their quest to become a biotech superpower.
On today’s Big Take Asia Podcast, host K. Oanh Ha, Bloomberg’s Karoline Kan and Oxford University geneticist Andy Greenfield discuss China’s pharmaceutical ambitions and the loose regulatory environment that allows the animal testing industry to thrive.
Read more: China Pushes Boundaries With Animal Testing to Win Global Biotech Race

The Domino Effect of the ‘Donroe Doctrine’
19:44

Trump’s Latest Target: Corporate Landlords
18:56

Pressure Is Mounting on Iran's Regime
19:26